))
Interview with Dr. Paul Stoffels, Johnson & Johnson
Manage episode 299555218 series 2872650
Inhoud geleverd door Maria C. Freire, Ph.D. and Maria C. Freire. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Maria C. Freire, Ph.D. and Maria C. Freire of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and monitoring emerging variants.
Along with Dr. Francis Collins, Director of NIH, Dr. Stoffels co-chairs Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), the historic public-private partnership created to combat COVID-19 on all fronts.
7 afleveringen
Delen
